Everence Capital Management’s Avidity Biosciences RNAM Stock Holding History

Everence Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,851	Closed	-$350K	–	879
2025 Q4	$350K	Hold	4,851	–	–	0.02%	530
2025 Q3	$211K	Buy	+4,851	New	+$196K	0.01%	755

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Everence Capital Management's RNAM Position: Q1 2026 in Review

Everence Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,851 shares — an estimated $350K sold.

Everence Capital Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $350K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Everence Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 4,851 Avidity Biosciences shares in Q1 2026, an estimated $350K.
Everence Capital Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Everence Capital Management's Avidity Biosciences position peaked at $350K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.